Ambu A/S (OTCMKTS:AMBBY) Rating Increased to Buy at DNB Markets
Ambu A/S (OTCMKTS:AMBBY) Rating Increased to Buy at DNB Markets
Ambu A/S (OTCMKTS:AMBBY – Get Rating) was upgraded by stock analysts at DNB Markets from a "hold" rating to a "buy" rating in a research note issued to investors on Thursday, The Fly reports.
The Fly报道，在周四向投资者发布的一份研究报告中，DNB Markets的股票分析师将Ambu A/S（场外交易代码：AMBBY — 获取评级）的评级从 “持有” 上调至 “买入”。
Separately, JPMorgan Chase & Co. increased their price target on Ambu A/S from 64.00 to 65.00 and gave the stock an "underweight" rating in a report on Wednesday, December 14th.
另外，摩根大通在12月14日星期三的一份报告中将Ambu A/S的目标股价从64.00上调至65.00，并将该股评为 “减持”。
Ambu A/S Price Performance
Ambu A/S 价格表现
OTCMKTS:AMBBY opened at $14.55 on Thursday. The company has a 50 day simple moving average of $14.35 and a two-hundred day simple moving average of $11.99. Ambu A/S has a fifty-two week low of $8.08 and a fifty-two week high of $19.25.
OTCMKTS: AMBBY周四开盘报14.55美元。该公司的50天简单移动平均线为14.35美元，两百天简单移动平均线为11.99美元。Ambu A/S的五十二周低点为8.08美元，五十二周高点为19.25美元。
About Ambu A/S
关于 Ambu A/S
(Get Rating)
（获取评分）
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope.
Ambu A/S 从事医院和救援服务的诊断和生命支持设备的开发、生产和销售。它通过以下部门运作：麻醉；患者监测和诊断；以及可视化。麻醉部门提供从呼吸器、口罩和喉罩到一次性灵活插管内窥镜等产品。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Ambu A/S (AMBBY)
- Wall Street Sees 23% Upside In Revance, Maker Of Botox Competitor
- Has Workhorse Group Finally Hit Bottom?
- Target Offering A Rare Buying Opportunity After Earnings
- Rivian Gives Investors a Taste of the Anxiety Its Consumers Feel
- 3 High-Yield Dividend Stocks That Are Probably Not On Your Radar
- 免费获取 StockNews.com 关于 Ambu A/S (AMBBY) 的研究报告
- 华尔街认为肉毒杆菌毒素竞争对手Revance有23％的上涨空间
- Workhorse 集团终于触底了吗？
- Target 在盈利后提供难得的买入机会
- Rivian 让投资者体会到其消费者所感受到的焦虑
- 3只可能不在你的关注范围内的高收益股息股票
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
接收Ambu A/S Daily的新闻和评级——在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收Ambu A/S及相关公司的最新新闻和分析师评级的简明每日摘要。